ICM dose reduction

Our completed clinical study demonstrates that the quality reserve provided by our technology can be effectively converted to significant contrast media (50%) reduction in carotid angiography. This brings significant economical and health benefits - less adverse events, contrast induced nephropathy - to the patients and cost saving for the cath labs. The clinical study was published in the European Journal of Radiology Open.

Low dose
DSA · 3 ml bolus
Low dose
DVA · 3 ml bolus
Carotid angiography
GE Innova IGS 530 · ICM: Xenetix 350 mg iodine/mL

REQUEST a demo

Get in touch with us and let us show you how we can make X-ray angiography safer and more powerful with Kinepict.

By clicking “Request a demo” you accept our Privacy Policy.